You are subscribed to the Formulary Issue Alert.

Formulary Issue Alert

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

December 19, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

CHECK OUT OUR LATEST ISSUE

Focus on tapentadol: Role in the treatment of neuropathic pain

Neuropathic pain is a difficult-to-treat condition; pathologic changes in neuronal pathways may result in suboptimal analgesic control with opioid agents alone. » More

High-dose isotretinoin reduces risk of acne vulgaris relapse

Higher doses of isotretinoin can effectively treat patients with acne vulgaris and reduce the relapse rate without significant increased adverse events, according to a recent report published in JAMA Dermatology. » More

Warnings on kids’ cold products slashed ER visits

After manufacturers began printing new warnings on medicine bottles, a smaller percentage of emergency room visits resulted from children taking cold and cough products, according to a study in Pediatrics. » More

Collaborative care to boost medication adherence may not improve outcomes significantly

Collaborative care with pharmacists helped to boost medication adherence in patients with acute coronary syndrome after hospital discharge. However, after 12- month follow-up, the proportion of patients who achieved blood pressure and LDL-cholesterol goals were not significantly different from patients treated under usual care, according to a recent study published online for JAMA Internal Medicine. » More

Depression in the elderly: A pharmacist's perspective

Depression is a disease state that is commonly under-diagnosed and undertreated in patients over the age of 65 years. Elderly patients may differ from younger patients in the presentation of symptoms and in the prevalence of comorbidities. » More

 

Downloads

Formulary App - Download Formulary Digital Edition - Download

You are subscribed to the Formulary Issue Alert.

Related Articles

Pipeline preview

FDA actions in brief

New molecular entity

 
Powered by Modern Medicine Advanstar Medical Communications Group